RSV: Clinical Trials

1 trial for RSV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow RSV: new trials by email Literature Review of RSV trials Research Report on RSV

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus
zelicapavir, Placebo - RSV Infection, RSV
Phase 2RecruitingEnanta Pharmaceuticals, Inc1502026-07-092026-07-20

Narrower conditions

Respiratory Syncytial Virus Infections (1)

Broader conditions

Infections (1)  ·  Mononegavirales Infections (1)  ·  Paramyxoviridae Infections (1)  ·  Pneumovirus Infections (1)  ·  RNA Virus Infections (1)  ·  Virus Diseases (1)

Sponsors

Enanta Pharmaceuticals, Inc (1)

Countries

Thailand (1)